- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medincell SA (MEDCL)
Medincell SA stock price live, this page displays EPA MEDCL stock exchange data. View the MEDCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medincell SA real time stock price chart below.
What Is the Medincell SA Stock Price Today?
The Medincell SA stock price today is 29.90.
What Is the Stock Symbol for Medincell SA?
The stock symbol for Medincell SA is "MEDCL."
What Stock Exchange Does Medincell SA Trade On?
Medincell SA is listed and trades on the Paris stock exchange.
Is Medincell SA a Good Stock to Buy?
Determining whether Medincell SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDCL quote. (ISIN: FR0004065605)
What Is the Medincell SA Stock Price Today?
The Medincell SA stock price today is 29.90.
What Is the Stock Symbol for Medincell SA?
The stock symbol for Medincell SA is "MEDCL."
What Stock Exchange Does Medincell SA Trade On?
Medincell SA is listed and trades on the Paris stock exchange.
Is Medincell SA a Good Stock to Buy?
Determining whether Medincell SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDCL quote. (ISIN: FR0004065605)
29.90
+0.08(+0.27%)
Real-time Data·
Fair Value
An estimate of a Medincell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.80
30.20
52 wk Range
19.69
32.38
MEDCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Medincell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.8030.20
52 wk Range
19.6932.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MEDCL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medincell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
36.18
Upside
+21.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Why is Medincell stock plunging today?- Investing.com
Why is Teva Pharma stock surging today?- Investing.com
Medincell SA receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Why is Teva Pharma stock surging today?
- Investing.com
- Medincell SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 36.18
(+21.00% Upside)
Earnings
Latest Release
Sep 02, 2026
EPS / Forecast
-- / -0.14
Revenue / Forecast
-- / 6.8M
Compare MEDCL to Peers and Sector
Metrics to compare | MEDCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −34.3x | 16.1x | −0.2x | |
PEG Ratio | 0.67 | 0.08 | 0.00 | |
Price/Book | 350.2x | 2.5x | 2.6x | |
Price / LTM Sales | 44.2x | 2.4x | 2.8x | |
Upside (Analyst Target) | 21.0% | 47.2% | 60.5% | |
Fair Value Upside | Unlock | 1.6% | 7.8% | Unlock |
MedinCell S.A. engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France. The company offers UZEDY, a subcutaneous risperidone for the treatment of schizophrenia. It also develops mdc-TJK, a subcutaneous injection, which is in NDA stage for the treatment of schizophrenia; and mdc-CWM, a sustained-release formulation of celecoxib, which is in Phase III clinical trial for the treatment and reduction of post-operative pain and inflammation. In addition, the company engages in the development of products in preclinical stage, including mdc-WWM for contraception; mdc-STM for the treatment of malaria; and mdc-AbbVie-1. It has strategic collaborations with TEVA, AIC, ABBVIE, Unitaid, and Gates Foundation. The company was incorporated in 2003 and is headquartered in Jacou, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Medincell (MEDCL) Stock Price Today?
The Medincell stock price today is 29.90 EUR.
What Stock Exchange Does Medincell Trade On?
Medincell is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Medincell?
The stock symbol for Medincell is "MEDCL."
What Is the Medincell Market Cap?
As of today, Medincell market cap is 1.07B EUR.
What Is Medincell's Earnings Per Share (TTM)?
The Medincell EPS (TTM) is -0.94.
When Is the Next Medincell Earnings Date?
Medincell will release its next earnings report on Dec 09, 2026.
From a Technical Analysis Perspective, Is MEDCL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Medincell Stock Split?
Medincell has split 0 times.
How Many Employees Does Medincell Have?
Medincell has 141 employees.
What is the current trading status of Medincell (MEDCL)?
As of Nov 12, 2026, Medincell (MEDCL) is trading at a price of 29.90 EUR, with a previous close of 29.82 EUR. The stock has fluctuated within a day range of 29.80 EUR to 30.20 EUR, while its 52-week range spans from 19.69 EUR to 32.38 EUR.
What Is Medincell (MEDCL) Price Target According to Analysts?
The average 12-month price target for Medincell is 36.18 EUR, with a high estimate of 41 EUR and a low estimate of 31 EUR. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.